MARKETS
Earnings

Tempus AI Announces Publication Of Study Results In 'Nature Medicine' That Demonstrate The PRISM2 Pathology Foundation Model's Ability To Perform Clinically Important Diagnostic Tasks

Aug 4, 2026 · 08:36 AM ET· updated 2h ago

PRISM2 outperformed or matched existing slide-level foundation models across a comprehensive set of diagnostic, biomarker and patient outcome prediction tasks. Additionally, when further tuned to specifically predict

Share
Why It Matters

Tempus AI's new computer tool called PRISM2 can read medical slides and help doctors diagnose diseases as well as or better than other tools. This published research shows the tool works well, which might help doctors trust and use it more in real hospitals.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.